Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.

23/07/2026 Eastern Time in USA The Dow Jones Industrial Average dropped by 0.97%, closing at 51711.65 points; the Nasdaq Composite dropped by 2.15%, closing at 25137.69 points; the S&P 500 Index dropped by 1.21%, closing at 7408.3 points. Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

NVE Corporation: Overnight gain 54.8%, Surges Amid Blowout Quarterly Earnings and Dividend Announcement

**NVE Corporation: A Pioneer in Spintronics Technology** NVE Corporation, incorporated in the state of Minnesota in 1989, is headquartered in a suburb of Minneapolis. The company operates as a specialized developer and commercial provider of nanotechnology-based devices within the field of spintronics — a discipline that harnesses the intrinsic spin of electrons rather than their electrical charge as the fundamental operating principle. NVE's core product portfolio comprises high-performance sensors and couplers, which are widely deployed across a broad range of data acquisition and transmission applications.

**NVE Corporation(NVEC) Surges 54.8% Following Blowout Quarterly Results** Shares of NVE Corporation(NVEC) posted a remarkable single-session gain of 54.8%, ranking second among the top five after-hours movers in U.S. equities, bringing year-to-date gains to 134.1%. The rally was fueled by the company's stellar fiscal first-quarter results reported on July 22, 2026. NVE Corporation(NVEC) delivered earnings per share of $1.32, representing a robust year-over-year surge of 78.38%, while quarterly revenue reached $11.034 million, nearly doubling on an annual basis with an 80.89% year-over-year increase. Revenue for the quarter ended June 30, 2026, climbed 81% year-over-year, significantly exceeding market consensus estimates. Compounding the bullish sentiment, NVE Corporation(NVEC) announced a dividend distribution, underscoring management's confidence in the company's strong cash flow generation and commitment to delivering sustained shareholder returns. The dual catalysts of explosive earnings growth and dividend declaration collectively drove the exceptional share price appreciation.

NovoCure Ltd.: Overnight gain 28.4%, Surges Amid Record Revenue, Raised Guidance, and Regulatory Catalysts

**NovoCure Limited** was incorporated under the laws of Jersey on February 11, 2000, as a publicly listed limited liability company. The Company is principally engaged in the field of oncology, having independently developed a proprietary and innovative therapeutic modality known as Tumor Treating Fields (TTFields), which is designed for the clinical treatment of solid tumor malignancies.

**NovoCure Ltd. (NVCR) Surges 28.4% on Record Revenue, Raised Guidance, and Key Regulatory Milestones** NovoCure Ltd. (NVCR) shares soared 28.4% in a single session, driven by a confluence of strong fundamentals and catalysts. The company reported record Q2 FY2026 total net revenue of $184 million, up 15.6% year-over-year, with global active patient count rising 18.4% annually. Net loss attributable to shareholders narrowed 61% year-over-year, while adjusted EBITDA turned positive. Gross margin expanded to 77.6%. Management raised full-year revenue guidance to $710–$725 million, exceeding consensus estimates. Additionally, Optune Lua received European CE certification, accelerating commercial rollout across the region. The FDA is expected to render a decision on NovoCure's PMA application for TTFields therapy targeting non-small cell lung cancer brain metastases in Q4, amplifying near-term catalyst momentum. International revenue grew 24.5% year-over-year, with multiple positive factors converging to propel the stock's significant single-day advance.

Gentherm Incorporated: Overnight gain 26.5%, Surges Amid Record Revenue, Raised Guidance, FDA Clearance, and Merger Progress

**Gentherm Incorporated: Company Overview** Incorporated under the laws of the State of Michigan, Gentherm Incorporated is a global leader in thermal management and pneumatic comfort technologies. The Company operates through two distinct business segments: Automotive and Medical. The Automotive segment is engaged in the design, development, manufacturing, and sale of a comprehensive portfolio of products, including climate-controlled seating systems, climate-controlled interior solutions, lumbar and massage comfort systems, valve systems, and associated electronic components. The Medical segment is dedicated to patient temperature management, offering an extensive range of products designed to address critical care heating and cooling therapies, intraoperative normothermia maintenance, as well as temperature management systems for both acute and chronic care applications.

**Gentherm Incorporated (THRM) Surges 26.5% on Record Q2 Results and Raised Guidance** Shares of Gentherm Incorporated (THRM) rallied sharply by 26.5% in a single session, driven by a confluence of positive catalysts. The company reported record-breaking Q2 2026 results, with revenue reaching $416 million, up 11% year-over-year, while Non-GAAP EPS of $0.75 exceeded consensus estimates by $0.19. Full-year product revenue guidance was raised to $1.55–$1.65 billion. The company's medical division received FDA 510(k) clearance for ThermAffyx™, initiating commercialization, while the acquisition of IME expands its thermal pain management portfolio. The proposed merger with Modine remains on track, targeting revenues exceeding $3.5 billion by 2030. Additionally, Gentherm Incorporated (THRM) announced a $400 million share repurchase program over three years. Stifel analysts raised their price target from $38 to $44, reflecting strengthened confidence in the company's long-term growth trajectory.

The Top 10 Daily Gainers in the USA market are listed as follows:

Editor's note: This content was generated by Sahm's in-house AI-enabled SaaS tool and was reviewed by our editing team. Risk and Disclaimer: The content provided above is solely for informational purposes and does not represent the views or positions of Sahm Platform. While we strive for accuracy, we cannot guarantee the authenticity or completeness of the information contained in the provided content. We strongly recommend that investors consult with a qualified investment advisor when deemed necessary. Sahm Platform neither provides investment advice nor makes any representations or warranties concerning the accuracy, reliability, or completeness of the information in the content provided above. By using Sahm Platform, you acknowledge that you have read, understood, and agreed to the terms set forth in this disclaimer.